Literature DB >> 2516171

Biochemical nature of pyruvate dehydrogenase complex in the patient with primary lactic acidaemia.

A Kitano1, F Endo, Y Kuroda, S Aso, T Kawasaki, I Matsuda.   

Abstract

The biochemical nature of the pyruvate dehydrogenase complex (PDHC) in muscle was studied in a patient with pyruvate dehydrogenase complex deficiency. The enzyme activity was approximately 30% of the control level and the apparent Km value of the enzyme was similar to the control value. The immunoblot pattern of each subunit protein, E1 alpha, E1 beta, the component X, E2 and E3, was comparable to that of the control on both one- and two-dimensional electrophoresis, the staining of each subunit protein being reduced in intensity, corresponding to the reduced enzyme activity. The enzyme deficiency is likely to be quantitative rather than qualitative, although the actual mechanism is unknown.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2516171     DOI: 10.1007/bf01802031

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  12 in total

1.  Deficiency of the pyruvate dehydrogenase component in pyruvate dehydrogenase complex-deficient human fibroblasts. Immunological identification.

Authors:  L Ho; C W Hu; S Packman; M S Patel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

2.  Systemic deficiency of the first component of the pyruvate dehydrogenase complex.

Authors:  D S Kerr; L Ho; C M Berlin; K F Lanoue; J Towfighi; C L Hoppel; M M Lusk; C M Gondek; M S Patel
Journal:  Pediatr Res       Date:  1987-09       Impact factor: 3.756

3.  Properties of a newly characterized protein of the bovine kidney pyruvate dehydrogenase complex.

Authors:  J M Jilka; M Rahmatullah; M Kazemi; T E Roche
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

4.  Hyperammonaemia and lactic acidosis in a patient with pyruvate dehydrogenase deficiency.

Authors:  G K Brown; R D Scholem; S M Hunt; J R Harrison; A C Pollard
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

5.  Low immunogenicity of the common lipoamide dehydrogenase subunit (E3) of mammalian pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase multienzyme complexes.

Authors:  O L De Marcucci; A Hunter; J G Lindsay
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

6.  Mutation of the E1 alpha subunit of the pyruvate dehydrogenase complex, in relation to heterogeneity.

Authors:  A Kitano; F Endo; I Matsuda; S Miyabayashi; H H Dahl
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

7.  Purification and immunochemical studies of pyruvate dehydrogenase complex from rat heart, and cell-free synthesis of lipoamide dehydrogenase, a component of the complex.

Authors:  S Matuda; T Shirahama; T Saheki; S Miura; M Mori
Journal:  Biochim Biophys Acta       Date:  1983-10-13

8.  Immunochemical analysis of normal and mutant forms of human pyruvate dehydrogenase.

Authors:  C A Wicking; R D Scholem; S M Hunt; G K Brown
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

9.  The elementary reactions of the pig heart pyruvate dehydrogenase complex. A study of the inhibition by phosphorylation.

Authors:  D A Walsh; R H Cooper; R M Denton; B J Bridges; P J Randle
Journal:  Biochem J       Date:  1976-07-01       Impact factor: 3.857

10.  Pyruvate dehydrogenase complex activity in normal and deficient fibroblasts.

Authors:  K F Sheu; C W Hu; M F Utter
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more
  2 in total

Review 1.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

2.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.